Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Innovating on Biotech Investment Models: Likely--or Even Possible?

This article was originally published in Start Up

Executive Summary

With the lack of a public market, VCs have grown extremely chary of new investments: are there lessons to be learned for biotech investing from the models employed by device investors or other apparently lower-risk approaches, such as "defined liquidity ventures"?

Related Content

Growing Companies--Part II
Growing Companies--Part 1
The Impact of Incubators on Venture Investing


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts